scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...629025T |
P356 | DOI | 10.1371/JOURNAL.PONE.0029025 |
P932 | PMC publication ID | 3236238 |
P698 | PubMed publication ID | 22174947 |
P5875 | ResearchGate publication ID | 51884905 |
P50 | author | Thor G. Theander | Q54802168 |
Christian W. Wang | Q55182133 | ||
Robert W Sauerwein | Q60043950 | ||
Thomas Lavstsen | Q80377133 | ||
Cornelus C Hermsen | Q114367861 | ||
Louise Turner | Q43240630 | ||
P2093 | author name string | Steven B Mwakalinga | |
P2860 | cites work | Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans | Q24804115 |
Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions | Q24804747 | ||
Plasmodium falciparum variant surface antigen expression patterns during malaria | Q24811060 | ||
Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production | Q25257163 | ||
Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1 | Q27313623 | ||
Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle | Q27974520 | ||
Immunity to non-cerebral severe malaria is acquired after one or two infections | Q28139257 | ||
Transient cross-reactive immune responses can orchestrate antigenic variation in malaria | Q28264776 | ||
A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma | Q28384693 | ||
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes | Q29393314 | ||
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes | Q29618254 | ||
Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes | Q29618991 | ||
Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants | Q47886673 | ||
Preferential transcription of conserved rif genes in two phenotypically distinct Plasmodium falciparum parasite lines | Q47893123 | ||
Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity | Q47901577 | ||
The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer | Q47909162 | ||
Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family | Q47971150 | ||
A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria | Q48021609 | ||
A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies | Q33198902 | ||
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. | Q33365414 | ||
Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient | Q33510341 | ||
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies | Q33634689 | ||
Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer | Q33700519 | ||
Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies | Q33761565 | ||
Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. | Q34000292 | ||
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity | Q34008755 | ||
Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children | Q34290645 | ||
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens | Q34351117 | ||
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria | Q34364093 | ||
Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes | Q34601747 | ||
Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children | Q34721291 | ||
Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family | Q35220304 | ||
Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli | Q35223977 | ||
Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria | Q35783951 | ||
Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals | Q35901099 | ||
Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes | Q36399515 | ||
Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. | Q37204480 | ||
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. | Q37331646 | ||
Naturally acquired immunity to Plasmodium falciparum | Q37778937 | ||
Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections | Q38854883 | ||
Analysis of Plasmodium falciparum var genes expressed in children from Papua New Guinea | Q38998322 | ||
Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. | Q39001696 | ||
The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates | Q39324954 | ||
Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study | Q41932967 | ||
Protection against a malaria challenge by sporozoite inoculation | Q41937865 | ||
Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. | Q42052491 | ||
stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens | Q42689345 | ||
Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa | Q43932881 | ||
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. | Q44146886 | ||
Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction | Q44161485 | ||
Plasmodium falciparum infection causes proinflammatory priming of human TLR responses | Q44400436 | ||
Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains | Q44605152 | ||
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections | Q46184700 | ||
Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. | Q46809348 | ||
Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults. | Q47832295 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
antibody | Q79460 | ||
Plasmodium falciparum | Q311383 | ||
Plasmodium falciparum malaria | Q18554672 | ||
P304 | page(s) | e29025 | |
P577 | publication date | 2011-12-12 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers | |
P478 | volume | 6 |
Q49830014 | Antibodies in children with malaria to PfEMP1, RIFIN and SURFIN expressed at the Plasmodium falciparum parasitized red blood cell surface |
Q61447733 | Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Infections |
Q38625368 | Antigenic Variation in Plasmodium falciparum |
Q34257253 | Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure |
Q35568907 | Asymptomatic Plasmodium falciparum infection in children is associated with increased auto-antibody production, high IL-10 plasma levels and antibodies to merozoite surface protein 3. |
Q59330088 | Characterization of anti-EBA175RIII-V in asymptomatic adults and children living in communities in the Greater Accra Region of Ghana with varying malaria transmission intensities |
Q44168331 | Controlled Human Malaria Infection: Applications, Advances and Challenges. |
Q37548076 | Cross-reactive immune responses as primary drivers of malaria chronicity |
Q35211679 | Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres |
Q36124623 | Evidence for in vitro and in vivo expression of the conserved VAR3 (type 3) plasmodium falciparum erythrocyte membrane protein 1. |
Q36531224 | Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes |
Q90665758 | Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model |
Q48023074 | Genetic Diversity of the Plasmodium falciparum Glutamate-Rich Protein R2 Region Before and Twelve Years after Introduction of Artemisinin Combination Therapies among Febrile Children in Nigeria |
Q46286513 | Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India |
Q34636542 | Genetic polymorphism and amino acid sequence variation in Plasmodium falciparum GLURP R2 repeat region in Assam, India, at an interval of five years |
Q37675077 | Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil |
Q44169469 | Host immune evasion strategies of malaria blood stage parasite |
Q35833840 | IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria |
Q38728601 | Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum |
Q34276755 | Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children |
Q28550263 | Quantifying Transmission Investment in Malaria Parasites |
Q35998522 | Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia |
Q34348881 | Severe malaria is associated with parasite binding to endothelial protein C receptor |
Q34161839 | Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates |
Q60954894 | To B or Not to B: Understanding B Cell Responses in the Development of Malaria Infection |
Q35926729 | Trade-offs in antibody repertoires to complex antigens |
Search more.